Purchase Order N0025919P0240
- Not listed
- The Defense Health Agency awarded a firm fixed price purchase order contract to Abbott Rapid Diagnostics Informatics, Inc., a division of Abbott Laboratories, to provide a remote automated laboratory system (RALS) for glucometer integration. The $131,349.60 contract has a completion date of December 31, 2027 and does not utilize a set-aside designation. As a prime contractor, Abbott Rapid Diagnostics Informatics has prior experience integrating point-of-care medical devices and diagnostic...
- The Defense Health Agency awarded a $215,062.30 firm fixed-price purchase order to Abbott Rapid Diagnostics Informatics, Inc. on October 1, 2023, for the Nova Starstrip Glucose Module under a modification exercising an option period. The contract extends through September 30, 2026, and will be performed in Charlottesville, Virginia. Abbott Rapid Diagnostics Informatics, a subsidiary of Abbott Laboratories, specializes in point-of-care diagnostic device integration and provides Remote Automated...
- The Department of Defense (DoD) Defense Health Agency (DHA) awarded a $61,434 firm-fixed-price purchase order to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories, for the Roche Accu-Chek Inform II point-of-care testing module. The contract, which has a performance period through May 11, 2026, does not have a small business set-aside designation. Abbott Rapid Diagnostics Informatics, Inc. is an established provider of medical device integration software and...
- This federal contract award is for the provision of the RALS GLUCOSE - BATH solution by Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories. The contract, with a ceiling value of $378,400.00, was awarded on October 1, 2025 and has an ultimate completion date of September 30, 2026. It is a Blanket Purchase Agreement (BPA) call contract with a firm fixed price pricing type. The funding federal agency is the Veterans Integrated Service Network 2 (VISN 2), a civilian...
- This is a firm fixed-price purchase order contract awarded to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories, by the Defense Health Agency (DHA). The contract provides an annual license for the Roche AccuChek Inform point-of-care diagnostic system, with a contract ceiling value of $60,637.50 and a performance period through March 18, 2027. Abbott Rapid Diagnostics Informatics, Inc. is a for-profit organization that specializes in integrating medical devices and...
- This firm-fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories, for a LABORATORY SOFTWARE LICENSE. The contract has a ceiling value of $56,027.00 and an ultimate completion date of April 14, 2029. This award is not a set-aside contract. The contract provides for licensing of Abbott's Remote Automated Laboratory System (RALS) software, middleware, connectivity services, implementation,...
- This federal contract award is for the delivery of GENERAL CHEMISTRY ANALYZERS; AFINION 2 C medical devices to the U.S. government. The $50,400.00 fixed-price contract with economic price adjustment was awarded on July 8, 2025 to the prime contractor, Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract has an ultimate completion date of July 31, 2025 and was awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is not designated as...
- This is a $78,025.50 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories. The contract is for a Point of Care Glucometer Application/Module, with a period of performance through September 13, 2027. This award is not a set-aside contract. Abbott Rapid Diagnostics Informatics, Inc. is a specialized healthcare IT solutions provider that focuses on...
- The U.S. Defense Health Agency (DHA) awarded a $59,625 firm-fixed-price purchase order to Abbott Rapid Diagnostics Informatics, Inc., a division of Abbott Laboratories. The contract is for a software license for the Remote Automated Laboratory System (RALS) PLUS and CoaguChek devices. This order is not associated with a set-aside designation. The contract has an ultimate completion date of March 23, 2029. Abbott Rapid Diagnostics Informatics, Inc. is a major provider of software, connectivity,...
- This contract was awarded by the Indian Health Service, a civilian agency, to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories. The contract has a ceiling value of $81,599.75 and is a firm fixed-price purchase order. The award is for GLUCOMETERS SOFTWARE, with a period of performance through September 30, 2025. The contract is not set aside for any specific small business category. Abbott Rapid Diagnostics Informatics, Inc. is the prime contractor and specializes...
This federal contract award is for the purchase of Abbott Glucose Precision XCEED PRO/GLUCO modules by the Defense Health Agency (DHA). The contract was awarded to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories, and has a ceiling value of $59,565.00. The contract is a firm fixed-price purchase order with an ultimate completion date of April 7, 2022. This contract was not set aside for small businesses. The original solicitation indicates that this was a sole-source award to Abbott Rapid Diagnostics Informatics, Inc. due to the proprietary nature of the equipment and the need for connectivity upgrades to the existing Remote Automated Laboratory System (RALS) software. As a subsidiary of the larger Abbott Laboratories corporation, Abbott Rapid Diagnostics Informatics, Inc. has established itself as a critical technology partner for federal healthcare agencies, providing medical device integration services and software solutions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source | N0025919N0037 | Department of the Navy Bureau of Medicine and Surgery | Solicitation 1/1 | 3/25/19, 6:36 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $19.9k | 4/7/21 | |
| P00001 | Exercise an Option | $19.9k | 2/25/20 | |
| Not listed | Not listed | $19.9k | 4/5/19 |